Moxalactam plus ticarcillin or tobramycin for treatment of febrile episodes in neutropenic cancer patients
- 1 September 1984
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 144 (9) , 1766-1770
- https://doi.org/10.1001/archinte.144.9.1766
Abstract
Research from JAMA Internal Medicine — Moxalactam Plus Ticarcillin or Tobramycin for Treatment of Febrile Episodes in Neutropenic Cancer PatientsThis publication has 12 references indexed in Scilit:
- Piperacillin plus amikacin therapy v carbenicillin plus amikacin therapy in febrile, granulocytopenic patientsArchives of internal medicine (1960), 1982
- Enterococcal Superinfection and Colonization After Therapy with Moxalactam, a New Broad-Spectrum AntibioticAnnals of Internal Medicine, 1981
- Combination therapy with ticarcillin and sulfamethoxazole-trimethoprim for infections in patients with cancerArchives of internal medicine (1960), 1981
- Clinical pharmacology of moxalactam in patients with malignant diseaseAntimicrobial Agents and Chemotherapy, 1981
- Carbenicillin-trimethoprim/sulfamethoxazole versus carbenicillin-gentamicin as empiric therapy of infection in granulocytopenic patientsThe American Journal of Medicine, 1980
- A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patientsThe American Journal of Medicine, 1979
- Antibacterial Activity of a New 1-Oxa Cephalosporin Compared with That of Other β-Lactam CompoundsAntimicrobial Agents and Chemotherapy, 1979
- Bacteremia due to gram-positive cocci in patients with neoplastic diseaseThe American Journal of Medicine, 1979
- CEPHALOTHIN PLUS AN AMINOGLYCOSIDE IS MORE NEPHROTOXIC THAN METHICILLIN PLUS AN AMINOGLYCOSIDEThe Lancet, 1978
- ANTIBIOTIC SUSCEPTIBILITY TESTING BY A STANDARDIZED SINGLE DISK METHOD1966